Rogers Corp. Aktie News

CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”) plans to announce fourth quarter and full year 2025 results on February 17, 2026 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financi...

Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript

Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript

Rogers' third-quarter earnings of $0.90 per share beat analyst expectations of $0.69 by a wide margin. Industrial, electric vehicle, and aerospace segments drove double-digit sales growth for the engineered materials company.

Rogers Corporation ( ROG ) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT Company Participants Stephen Haymore - Director of Investor Relations Ali El-Haj - Interim President & Interim CEO Laura Russell - CFO, Senior VP & Treasurer Conference Call Participants Dan Moore - CJS Securities, Inc. Craig Ellis - B. Riley Securities, Inc., Research Division David Silver Presentation Operator Good ...

CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) today announced financial results for the third quarter of 2025. "Third quarter results were at the upper end of guidance due to improved end-market demand and good execution on cost improvement initiatives,” stated Ali El-Haj, Rogers' Interim President and CEO. "Compared to the prior quarter sales, gross margin, earnings, adjusted...

Roche Holding AG (OTCQX:RHHBY) Q3 2025 Sales Call October 23, 2025 8:00 AM EDT Company Participants Thomas Schinecker - Group Chief Executive Officer Alan Hippe - Chief Financial Officer Teresa Graham - Chief Executive Officer of Roche Pharmaceuticals Matthew Sause - Chief Executive Officer Bruno Eschli - Head of Investor Relations Conference Call Participants Richard Vosser - JPMorgan Chase & ...

Roche Holding AG (OTCQX:RHHBY) Shareholder/Analyst Call October 21, 2025 11:00 AM EDT Company Participants Bruno Eschli - Head of Investor Relations Nilesh Mehta - Global Franchise Head - Ophthalmology Chris Brittain - Global Head of Ophthalmology Product Development & VP Conference Call Participants Nisha Acharya César Briceño Michael Leuchten - Jefferies LLC, Research Division Peter Verdult -...